Relationship Between Health-Related Quality of Life and Work Productivity in Patients With Ulcerative Colitis in the Tofacitinib OCTAVE Phase 3 Induction and Maintenance Studies

被引：0
|
作者：
Targownik, Laura [1 ]
Dubinsky, Marla C. [2 ]
Steinwurz, Flavio [3 ]
Bushmakin, Andrew G. [4 ]
Cappelleri, Joseph C. [4 ]
Tai, Elaine [5 ]
Gardiner, Sean [6 ]
Hur, Peter [6 ]
Panes, Julian [7 ]
机构：
[1] Univ Toronto, Mt Sinai Hosp, Toronto, ON, Canada
[2] Icahn Sch Med Mt Sinai, Susan & Leonard Feinstein IBD Ctr, New York, NY 10029 USA
[3] Hosp Israelita Albert Einstein, Unit Inflammatory Bowel Dis, Sao Paulo, SP, Brazil
[4] Pfizer Inc, Groton, CT 06340 USA
[5] Pfizer Canada, Kirkland, PQ, Canada
[6] Pfizer Inc, New York, NY USA
[7] Hosp Clin Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1040
引用
收藏
页码：S753 / S754
页数：2
相关论文
共 50 条
  • [11] Health-related quality of life, work productivity, and persisting challenges in treated ulcerative colitis patients: a Japanese National Health and Wellness Survey
    Hiraoka, Sakiko
    Huang, Zhezhou
    Qin, Fei
    Arokianathan, Fatima Megala Nathan
    Dave, Kiran
    Shah, Shweta
    Kim, Hyunchung
    INTESTINAL RESEARCH, 2025,
  • [12] Maintenance of quality of life improvement in a phase 3 study of tofacitinib for patients with moderately to severely active ulcerative colitis
    Panes, J.
    Rubin, D. T.
    Vermeire, S.
    Lindsay, J. O.
    Sands, B. E.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S315 - S317
  • [13] MAINTENANCE OF QUALITY OF LIFE IMPROVEMENT IN A PHASE 3 STUDY OF TOFACITINIB FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Panes, J.
    Rubin, D. T.
    Vermeire, S.
    Lindsay, J. O.
    Sands, B. E.
    Su, C.
    Friedman, G.
    Zhang, H.
    Kayhan, C.
    Manuchehri, A.
    Healey, P.
    GUT, 2017, 66 : A121 - A122
  • [14] MAINTENANCE OF QUALITY OF LIFE IMPROVEMENT IN A PHASE 3 STUDY OF TOFACITINIB FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Panes, Julian
    Rubin, David T.
    Vermeire, Severine
    Lindsay, James O.
    Sands, Bruce E.
    Su, Chinyu
    Friedman, Gary
    Zhang, Haiying
    Kayhan, Cem
    Manuchehri, Alireza
    Healey, Paul J.
    GASTROENTEROLOGY, 2017, 152 (05) : S601 - S602
  • [15] Assessment of Health-Related Quality of Life and Patient-Reported Outcomes With Tofacitinib Treatment Stratified by Age in Patients From the OCTAVE Ulcerative Colitis Clinical Program
    Dubinsky, Marla C.
    Biedermann, Luc
    Hart, Ailsa
    Panes, Julian
    Rubin, David T.
    Fellmann, Marc
    Gardiner, Sean
    Paulissen, Jerome
    Almadi, Majid A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S741 - S742
  • [16] Guselkumab maintenance treatment improves health-related quality of life in patients with moderately to severely active Ulcerative Colitis: Phase 3 QUASAR maintenance study
    Bressler, B.
    Peyrin-Biroulet, L.
    Afif, W.
    Samaan, M. A.
    Wei, S. C.
    Yarandi, S.
    Germinaro, M.
    Mistry, P.
    Han, C.
    Allegretti, J. R.
    Lichtenstein, G. R.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2133 - i2135
  • [17] ANALYSIS OF HEMATOLOGICAL CHANGES IN TOFACITINIB-TREATED PATIENTS WITH ULCERATIVE COLITIS ACROSS PHASE 3 INDUCTION AND MAINTENANCE STUDIES
    Lichtenstein, Gary R.
    Moore, Gregory T.
    Soonasra, Arif
    Nduaka, Chudy I.
    Kwok, Kenneth
    Wang, Lisy
    Lawendy, Nervin
    Chan, Gary
    Su, Chinyu
    Loftus, Edward V.
    GASTROENTEROLOGY, 2019, 156 (06) : S1111 - S1111
  • [18] Analysis of haematological changes in tofacitinib-treated patients with ulcerative colitis across Phase 3 induction and maintenance studies
    Lichtenstein, G. R.
    Moore, G. T.
    Soonasra, A.
    Nduaka, C. I.
    Kwok, K.
    Wang, L.
    Lawendy, N.
    Chan, G.
    Su, C.
    Loftus, E. V., Jr.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S351 - S352
  • [19] Tofacitinib in Ulcerative Colitis: The Relationship Between OCTAVE Induction Week 8 Symptomatic Remission and OCTAVE Sustain Week 52 Remission
    Desreumaux, Pierre
    Akyuz, Filiz
    Ha, Christina
    Bouzidi, Amira
    Tamzali, Amel
    Gardiner, Sean
    Wu, Joseph
    Paulissen, Jerome
    Vuitton, Lucine
    Regueiro, Miguel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S913 - S914
  • [20] Ustekinumab Improved Work Productivity in Patients With Moderate to Severe Ulcerative Colitis: Results From the Phase 3 UNIFI Induction and Maintenance Studies
    Han, Chenglong
    Naessens, Dominik
    Zhang, Hongyan
    Johanns, Jewel
    Marano, Colleen
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S438 - S438
12345